Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta, Precision Therapeutics Reach Co-marketing Deal for miRview mets2 Assay

NEW YORK (GenomeWeb News) – Rosetta Genomics today announced a deal with Precision Therapeutics to co-market Rosetta's miRview mets2 assay.

Under the terms of the agreement, the two firms will co-market in the US through July 30, 2014 the microRNA-based assay for the identification of the tumor of origin in cancers of unknown or uncertain primary (CUP). The deal includes certain pre-specified performance milestones.

Rosetta will continue to record all revenues for the test and will be responsible for sample collection, processing, and billing, it said. Precision is expected to launch its miRview mets2 co-marketing effort next month.

Other terms of the deal were not disclosed.

"With approximately 200,000 CUP patients in the US, we believe this co-marketing agreement will significantly enhance our reach and access to the physicians who diagnose cancer and who treat these patients, including pathologists and oncologists," Rosetta President and CEO Kenneth Berlin said in a statement.

In May, a designated Medicare contractor said that it would cover the assay. That decision, along with today's agreement, he added, "significantly strengthens our prospects for widespread market adoption and revenue growth."

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.